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In vitro and in vivo screening for 
novel essential cell-envelope 
proteins in Pseudomonas 
aeruginosa
Regina Fernández-Piñar1, Alessandra Lo Sciuto1, Alice Rossi2, Serena Ranucci2, 
Alessandra Bragonzi2 & Francesco Imperi1,3
The Gram-negative bacterium Pseudomonas aeruginosa represents a prototype of multi-drug 
resistant opportunistic pathogens for which novel therapeutic options are urgently required. In 
order to identify new candidates as potential drug targets, we combined large-scale transposon 
mutagenesis data analysis and bioinformatics predictions to retrieve a set of putative essential genes 
which are conserved in P. aeruginosa and predicted to encode cell envelope or secreted proteins. By 
generating unmarked deletion or conditional mutants, we confirmed the in vitro essentiality of two 
periplasmic proteins, LptH and LolA, responsible for lipopolysaccharide and lipoproteins transport to 
the outer membrane respectively, and confirmed that they are important for cell envelope stability. 
LptH was also found to be essential for P. aeruginosa ability to cause infection in different animal 
models. Conversely, LolA-depleted cells appeared only partially impaired in pathogenicity, indicating 
that this protein likely plays a less relevant role during bacterial infection. Finally, we ruled out any 
involvement of the other six proteins under investigation in P. aeruginosa growth, cell envelope 
stability and virulence. Besides proposing LptH as a very promising drug target in P. aeruginosa, this 
study confirms the importance of in vitro and in vivo validation of potential essential genes identified 
through random transposon mutagenesis.
The Gram-negative bacterium Pseudomonas aeruginosa is currently regarded as one of the most dreaded 
opportunistic pathogens in hospitals, and belongs to the “ESKAPE pathogens” group due to its propen-
sity to “escape” antibiotic treatments1. P. aeruginosa is also the main cause of chronic lung infection and 
mortality in individuals with cystic fibrosis (CF), which is the most common fatal genetic disease in the 
Caucasian population2. A hallmark of P. aeruginosa infections is the life-threatening severity and poor 
responsiveness to currently available antibiotic therapies3. Besides its intrinsic resistance to many widely 
used antibiotics, that is mostly due to low membrane permeability and active drug efflux, P. aeruginosa 
also managed to acquire resistance via additional mechanisms, including target modification, increased 
expression of efflux pumps and acquisition of new drug-resistance genes by horizontal gene transfer4,5. 
As a result, pan-resistance to currently used antibiotics in clinical P. aeruginosa isolates has already been 
reported5,6. Despite the growing concern of clinicians about the very limited number of therapeutic 
options to fight multi-resistant P. aeruginosa strains, only a very small number of new anti-Pseudomonas 
drugs are currently in late stage of pre-clinical or clinical development7,8. In this scenario, there is an 
impelling need for the identification of novel drug targets and the discovery of new-generation antibiot-
ics active against P. aeruginosa.
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A whole genome in silico study has predicted that about 38% of the P. aeruginosa genome (cor-
responding to more than 2,100 genes) encodes for proteins that are located in the cell envelope or 
secreted in the extracellular milieu9. Gram-negative bacteria have a typical diderm cell organization, 
with a cell envelope consisting of a peptidoglycan-containing periplasmic space sandwiched between 
the cytoplasmic (or inner) membrane and the outer membrane, which is an asymmetric bilayer with 
an inner leaflet of phospholipids and an outer leaflet of lipopolysaccharide (LPS)10. Periplasmic and 
outer membrane proteins are mainly translocated through the cytosplasmic membrane via the general 
secretory (Sec) or twin-arginine translocation (TAT) pathways, that recognize target proteins by means 
of specific N-terminal signal peptides11.
Cell envelope proteins are involved in different cellular processes, including cell-wall assembly and 
stability, nutrient uptake, energy production, adherence, motility, environmental sensing, virulence, and 
antibiotic resistance. In the last decade, several proteomics studies focused on the characterization of the 
P. aeruginosa membrane and periplasmic compartments (reviewed in12), revealing that about one third 
of the P. aeruginosa outer membrane and periplasmic proteins cannot be assigned to any functional class 
on the basis of sequence homology13. Taken together, the relevance of the cell envelope for the physiology 
of Gram-negative bacteria and the poor functional characterization of the cell envelope sub-proteomes 
of P. aeruginosa suggest that the extracytoplasmic compartments of P. aeruginosa cells could represent a 
promising reservoir of still-unexplored protein functions to be investigated as potential targets for drug 
development.
Two large-scale transposon mutagenesis projects, focused on two different strains of P. aeruginosa 
(PAO1 and PA14), led to the identification of 335 genes shared by the two strains that were not disrupted 
in more than 60,000 defined transposon insertion mutants14,15. A probabilistic calculation of 60,000 ran-
dom insertions over 6.5 megabases (i.e. the average size of the P. aeruginosa genome) suggested that a 
gene 327 bp in length should have a 95% probability of being disrupted by random transposon inser-
tion15, indicating that undisrupted genes larger than 327 bp are good candidates as potential essential 
genes.
Based on this information, we retrieved eight candidate essential genes of P. aeruginosa (undisrupted 
in the two transposon mutagenesis studies described above) that (i) are longer than 327 bp, (ii) have 
not previously been confirmed as essential genes in P. aeruginosa, (iii) are present in all P. aeruginosa 
genomes sequenced so far, and (iv) encode proteins with a predicted cell-envelope localization (Table 1). 
The role of the selected proteins in P. aeruginosa growth in vitro, cell envelope stability and pathogenicity 
in different animal models of infection was investigated in order to evaluate their suitability as potential 
targets for the development of novel anti-P. aeruginosa drugs.
Results
Generation of deletion and conditional mutants, and in vitro growth assays. With the aim 
of characterizing novel P. aeruginosa proteins involved in cell envelope biogenesis and/or homeosta-
sis, we focused our attention on eight genes that were previously proposed to be essential due to the 
PAO1 ID Gene name
PA14 
ortholog
Signal 
peptide1
Transmembrane 
helix (TMH)2
Subcellular 
localization3 Protein function Gene length (bp)
PA0517 nirC PA14_06730 Yes No Periplasm C-type cytochrome precursor 360
PA1645 PA14_43230 Yes No Non-cytoplasmic4 Hypothetical protein 408
PA1981 PA14_38880 Yes No Extracellular Hypothetical protein 648
PA2614 lolA PA14_30310 Yes No Periplasm Periplasmic chaperone LolA 627
PA3786 PA14_15110 No
1 (N-terminal, 
in → out 
orientation)5
IM Hypothetical protein 390
PA4460 lptH PA14_57920 Yes No Periplasm LPS transport protein LptA 527
PA4485 PA14_58210 Yes6 No OM7 Conserved hypothetical protein 378
PA5126 PA14_67700 No
1 (N-terminal, 
in → out 
orientation)5
IM Hypothetical protein 468
Table 1. Selected candidate essential genes of P. aeruginosa PAO1 investigated in this study. 1Predicted 
by SignalP 4.1 (http://www.cbs.dtu.dk/services/SignalP/). 2Predicted by TMHMM Server 2.0 (http://www.
cbs.dtu.dk/services/TMHMM/). 3Predicted by PSORTb (http://www.psort.org/psortb/). Abbreviations: 
OM, outer membrane; IM, inner membrane. 4According to PSORTb, this protein has an equal probability 
of having an IM, periplasmic, OM or extracellular localization. 5This protein is predicted to be anchored 
to the IM by means of a single N-terminal TMH, with the bulk of the protein exposed to the periplasmic 
space. 6Putative lipoprotein according to LipoP 1.0 Server (http://www.cbs.dtu.dk/services/LipoP/). 7The OM 
localization of this putative lipoprotein was predicted by ref. 30.
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inability to obtain transposon insertion mutants in more than 60,000 defined transposition events14,15, 
and that encode proteins with a predicted cell envelope localization (Table 1). Five of these genes encode 
hypothetical proteins whose function cannot be predicted on the basis of sequence homology (www.
pseudomonas.com), while the remaining genes encode a putative c-type cytochrome or homologues of 
the Escherichia coli LolA and LptA proteins, which are responsible for the transport of lipoproteins or 
LPS across the periplasm to the outer membrane, respectively16,17. Due to the presence of another gene 
named lptA in the P. aeruginosa genome, which encodes a lysophosphatidic acid acyltransferase, the 
LptA homologue of P. aeruginosa has recently been renamed LptH18. A further candidate gene which 
fulfilled our selection criteria, PA3988 (encoding an homologue of the outer membrane protein LptE of 
E. coli), was not included in the screening since it is predicted to be involved in the same LPS transport 
pathway of LptH17.
In order to verify the essentiality of the genes of interest, we first attempted to generate unmarked 
in-frame deletion mutants in the reference strain P. aeruginosa PAO1. Surprisingly, we obtained a dele-
tion mutant in six genes of interest (PA0517, PA1645, PA1981, PA3786, PA4485 and PA5126; Table 2), 
including all the genes encoding proteins with unpredictable function. This evidence clearly rules out 
that these genes are strictly essential for P. aeruginosa growth in vitro, as confirmed by the finding that 
all the deletion mutants showed growth yields and kinetics overall comparable to those of the wild type 
strain, both in Mueller-Hinton (MH) broth (Fig.  1a) and in MH agar plates (Supplementary Fig. S1), 
as well as in other complex (LB) or minimal media (M9 supplemented with different carbon sources) 
(Supplementary Fig. S2).
In contrast, several attempts to generate deletion mutants in lptH and lolA failed, suggesting that 
these two genes are important for P. aeruginosa growth and/or viability, at least under our experimental 
conditions. To confirm this hypothesis, we generated lptH and lolA conditional mutants carrying an 
arabinose-inducible copy of each gene of interest in a neutral site of the genome and an in-frame deletion 
in the endogenous gene (Table 2), and assessed their ability to grow in MH broth in the presence or in 
the absence of arabinose. The growth of both conditional mutants was strongly impaired in MH broth, 
but was restored to wild type levels in the presence of arabinose (Fig.  1b), confirming the relevance 
of both LolA and LptH for P. aeruginosa growth as well as the reliability of our conditional mutants. 
Notably, while the lptH conditional mutant did not grow at all in the absence of arabinose, the lolA con-
ditional mutant showed some residual growth (Fig. 1b). This was confirmed by measuring the number 
of colony-forming units (CFU) over time. As shown in Fig. 1c, the lolA conditional mutant incubated in 
MH without arabinose was able to perform about six generations before stabilizing at a cell density about 
8.5 fold lower than the wild type. In contrast, lptH mutant cells only completed a couple of generations 
in the absence of arabinose before beginning to die (Fig. 1c). Comparable growth profiles were obtained 
in different complex or minimal media (Supplementary Fig. S2). Overall, these results indicate that, in 
our experimental conditions, LptH is essential for both P. aeruginosa growth and cell viability, while LolA 
only appears to be important for growth.
Cell envelope stability. Since all the genes of interest encode proteins that are predicted to be located 
in the cell envelope or, in the case of PA1981, secreted into the extracellular milieu (Table 1), the pos-
sible role of these proteins in cell envelope biogenesis and/or stability was assessed through a sodium 
Strain Genotype and/or relevant characteristics Reference/source
P. aeruginosa
 PAO1 (ATCC15692) Prototroph American type culture collection
 PAO1 Δ PA0517 PAO1 with an in-frame deletion of the PA0517 gene This study
 PAO1 Δ PA1645 PAO1 with an in-frame deletion of the PA1645 gene This study
 PAO1 Δ PA1981 PAO1 with an in-frame deletion of the PA1981 gene This study
 PAO1 Δ PA3786 PAO1 with an in-frame deletion of the PA3786 gene This study
 PAO1 Δ PA4485 PAO1 with an in-frame deletion of the PA4485 gene This study
 PAO1 Δ PA5126 PAO1 with an in-frame deletion of the PA5126 gene This study
 PAO1 araCPBADlolA Δ lolA
PAO1 with an arabinose-inducible copy of lolA (PA2614) inserted into the 
attB neutral site and an in-frame deletion of the endogenous copy of lolA This study
 PAO1 araCPBADlptH Δ lptH
PAO1 with an arabinose-inducible copy of lptH (PA4460) inserted into the 
attB neutral site and an in-frame deletion of the endogenous copy of lptH This study
E. coli
 S17.1λ pir thi pro hsdR hsdM+ recA RP4-2-Tc::Mu-Km::Tn7 λpir, GmR 41
 DH5α F’ recA1 endA1 hsdR17 supE44 thi-1 gyrA96 relA1 Δ (lacZYA-argF)U169[φ 80 dlacZΔ M15], NalR 42
Table 2.  Bacterial strains used in this study.
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dodecyl sulphate (SDS) sensitivity assay. Deletion mutants were grown in MH, washed once with saline, 
and resuspended in saline in the presence of increasing concentrations of SDS. Since the expression of 
the LptH and LolA proteins was found to be essential for the growth of the P. aeruginosa lolA and lptH 
conditional mutants in vitro (Fig. 1), a previously-developed culturing strategy was employed to obtain 
P. aeruginosa cells depleted of each protein of interest19. Briefly, the lptH and lolA conditional mutants 
were grown in MH in flasks for 14 h in the presence of 0.5% (lptH mutant) or 0.1% arabinose (lolA 
mutant), and then two successive refreshes (1:30 dilution) were performed in the absence of arabinose. 
As soon as a growth defect was observed in the conditional mutants with respect to wild type cultures 
(dashed box in Fig. 2a), cells were collected and tested for SDS sensitivity. All deletion mutants showed 
an SDS sensitivity profile comparable to that of the wild type strain PAO1 (Fig. 2b). On the other hand, 
LptH- and LolA-deficient cells were much more sensitive to the lytic effect of SDS, although the defect 
in SDS resistance was more pronounced in the lptH conditional mutant compared to the lolA conditional 
mutant (Fig.  2b). Notably, SDS resistance was restored to wild type levels in both mutants when they 
were cultured in the presence of 0.5% arabinose (Supplementary Fig. S3). In the whole, this experiment 
demonstrates that LptH and, to a lesser extent, LolA are the only proteins here investigated with a rele-
vant role in cell envelope stability.
Pathogenicity in Galleria mellonella. Since laboratory cultures could not reflect bacterial growth 
during infection, each deletion or conditional mutant was also tested in a model of infection based on 
the larvae of the insect G. mellonella, which represents a convenient and easy-to-handle animal model 
to screen the pathogenicity of P. aeruginosa mutants20. All the deletion mutants showed lethality curves 
Figure 1. Role of each protein of interest in P. aeruginosa growth in vitro. (a) Growth curves of the 
wild type strain PAO1 and the PA0517, PA1645, PA1981, PA3786, PA4485 and PA5126 deletion mutants 
in MH broth at 37 °C in microtiter plates at 200 rpm. The generation time (Tg) of each strain is reported 
in the figure. Results are the mean of three independent experiments, with standard deviations (SD) being 
< 10% of the values. (b,c) Growth of PAO1 and lptH and lolA conditional mutants in MH broth at 37 °C 
in microtiter plates at 200 rpm in the absence or in the presence of 0.5% arabinose (+ ara), after a 1:1000 
dilution from overnight cultures in MH supplemented with 0.5% arabinose. Growth was measured as OD600 
(panel b) or CFU/ml (panel c). Results are the mean (± SD) of three independent experiments.
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similar to that of the wild type strain (Fig. 3 and Supplementary Fig. S4), indicating that none of them 
was relevantly impaired in pathogenicity in this model of infection. This was confirmed by a less-than-
2-fold change between the lethal dose 90% (LD90) values of mutants and wild type, with the only excep-
tion of PAO1 Δ PA1981, whose LD90 was 2.5-fold higher than that of PAO1 (Table  3). In agreement 
with the results of the growth assays, the lptH and lolA conditional mutants were found to be signifi-
cantly impaired in infectivity in G. mellonella larvae, although a remarkable difference in the pathogenic 
behaviour of the two strains was observed. Indeed, while the lptH conditional mutant showed an LD90 
of 1.6 × 107 cells, in line with that recently determined in the same model of infection for P. aeruginosa 
conditional mutant cells lacking the essential periplasmic protein TolB19, the LD90 of the lolA conditional 
mutant was about 60 cells, less than 25-fold higher than that of the wild type (Table 3). To verify that the 
observed lethality of the lolA mutant was related to active growth in vivo rather than to increased toxicity 
of LolA-depleted cells, we infected five G. mellonella larvae with about 500 cells of the wild type PAO1 
and the lolA conditional mutant, and determined the number of viable cells in the hemolymph of dead 
larvae on selective plates supplemented or not with 0.5% arabinose. The number of viable cells per larva 
determined on arabinose-containing plates was comparable between the wild type and the lolA condi-
tional mutant [1.6 (± 0.3) × 1010 and 2.1 (± 0.4) × 1010, respectively)], while the number of CFU on plates 
without arabinose was below the detection limit of the assay (250 cells) for lolA-infected larvae. Overall, 
these results indicate that, although impaired in virulence with respect to the wild type, the lolA condi-
tional mutant is still able to grow and cause infection in G. mellonella, suggesting that LolA depletion 
could be less important for P. aeruginosa growth in vivo than that observed in selected laboratory media.
Pathogenicity in a mouse model of pulmonary infection. Considering the different behaviour 
of the lptH and lolA conditional mutants in the G. mellonella infection model, we assessed their patho-
genicity in a mouse model of acute lung infection21, in order to further verify their suitability as anti-P. 
aeruginosa drug targets. A preliminary experiment revealed that a dose corresponding to 107 cells of 
our wild type strain was necessary to cause 100% lethality in this infection model (Supplementary Fig. 
S5). We then compared the pathogenicity of the wild type and each conditional mutant at two different 
Figure 2. Effect of depletion of each protein of interest on cell envelope stability. (a) Growth of PAO1 
and the lptH and lolA conditional mutants at 37 °C in MH broth at 200 rpm in flasks after two successive 
subcultures in the absence of arabinose, in order to obtain cells depleted of the LptH or LolA protein. 
Bacteria were cultured for 14 h at 37 °C and 200 rpm in MH supplemented with 0.1% (PAO1 and the lolA 
conditional mutant) or 0.5% arabinose (lptH conditional mutant) (not shown in the figure) and then diluted 
1:30 in fresh medium without arabinose (time 0). After 3 h of growth, cultures were diluted again 1:30 in 
fresh medium and incubated at 37 °C until the appearance of a growth defect in the conditional mutants 
with respect to the wild type. (b) Lytic effect of different SDS concentrations (0–5%), measured as decrease 
in cell suspension turbidity (OD600), on PAO1 wild type cells, the PA0517, PA1645, PA1981, PA3786, PA4485 
and PA5126 deletion mutant cells, and the LptH- or LolA-deficient conditional mutant cells (lptH and lolA, 
respectively) cultured as shown in panel a. The graphs are representative of three independent experiments 
giving similar results.
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infecting doses (107 and 108 cells). As expected, all mice infected with 107 cells of the wild type strain 
died within 48 h post infection (Fig.  4a). In contrast, at the same infecting dose, the lolA conditional 
mutant only caused lethality in 25% of mice, while the lptH conditional mutant was completely avirulent 
(Fig.  4a). Moreover, a significant difference in body weight recovery after the infection was observed 
between mice infected with the two conditional mutants (Fig.  4b), suggesting that the challenge with 
the lptH conditional mutant had a less deleterious effect on mice as compared to that with the lolA con-
ditional mutant. This was also confirmed by the observation that very high infecting doses (108 cells) 
caused 100% mortality within 36 h from the challenge in the case of the lolA conditional mutant, while 
mice infected with the lptH conditional mutant showed a significantly delayed mortality curve (Fig. 4a).
Discussion
The rise of antibacterial resistance among bacterial pathogens leads to a growing need for the identifi-
cation and development of novel antibacterial agents. Notably, the recent discovery of new promising 
antimicrobials with a completely new mechanisms of action22,23 indicates that we have only explored a 
fraction of the microbial targets that could be used for antibiotic drug discovery.
Rational development of antibacterial drugs with novel mechanisms of action requires the identi-
fication of new molecular targets, that may emerge from a better understanding of cellular processes 
Figure 3. Pathogenicity of selected P. aeruginosa mutants in the G. mellonella infection model. Survival 
curves, generated by the GraphPad Prism software, of G. mellonella larvae infected with different doses of 
P. aeruginosa PAO1, the lolA and lptH conditional mutants, and a representative deletion mutant (PAO1 
Δ PA3786). The survival curves for the remaining deletion mutants are shown in Supplementary Fig. S4.
Strain LD90 R2
PAO1 2.7 0.71
PAO1 Δ PA0517 2.3 0.78
PAO1 Δ PA1645 3.2 0.88
PAO1 Δ PA1981 6.8 0.73
PAO1 Δ PA3786 5.0 0.83
PAO1 Δ PA4485 4.8 0.78
PAO1 Δ PA5126 4.1 0.79
PAO1 araCPBADlolA Δ lolA 63.4 0.85
PAO1 araCPBADlptH Δ lptH 1.6 × 107 0.73
Table 3. Lethal dose 90% (LD90) in G. mellonella larvae for P. aeruginosa PAO1 and the isogenic 
deletion or conditional mutants analysed in this study1. 1The LD90 and R2 values were determined using 
the GraphPad Prism software and the survival curves shown in Fig. 3 or Supplementary Fig. S4.
www.nature.com/scientificreports/
7Scientific RepoRts | 5:17593 | DOI: 10.1038/srep17593
essential for cell survival and/or pathogenicity. In this view, large-scale systematic analysis of gene essen-
tiality represented an important step towards the characterization of novel potential drug targets. High 
density whole-genome transposon mutagenesis followed by sequence-based identification of insertion 
sites was the most frequently used approach to predict gene essentiality in bacterial species (http://
www.essentialgene.org/). However, transposon mutagenesis suffers from intrinsic biases that can lead to 
misannotation of some essential or non-essential genes24. Moreover, since gene essentiality prediction by 
random transposon mutagenesis relies on the inability to obtain mutants in a given gene, this approach 
does not allow to get information about the function of each putative essential protein or its suitability 
as a potential antibiotic target.
The present study was specifically aimed at verifying the in vitro and in vivo essentiality of selected 
P. aeruginosa cell-envelope proteins, in order to propose them as novel potential drug targets. The ration-
ale for focusing on cell envelope-located or surface-exposed proteins is linked to the fact that they are 
expected to be more accessible to drugs, and drug binding to cell envelope targets could avoid or delay 
later extrusion by efflux pumps, which represent key components of both intrinsic and acquired antibi-
otic resistance in P. aeruginosa25. Among the eight genes here investigated, only two were found to be 
required for P. aeruginosa growth in vitro, namely lptH and lolA (Fig. 1), responsible for the transport of 
LPS and lipoproteins to the outer membrane, respectively. In agreement with the predicted role of these 
proteins in outer membrane biogenesis, LptH- and LolA-depleted cells also showed increased sensitiv-
ity to the detergent SDS (Fig. 2). In contrast, the remaining genes (PA0517, PA1645, PA1981, PA3786, 
PA4485 and PA5126) appeared to be dispensable for P. aeruginosa growth in vitro and for cell envelope 
stability (Figs 1 and 2). This finding is in line with very recent Tn-seq studies reporting that transposon 
insertion mutants in these genes were able to grow in different growth media26,27. Here we also demon-
strate that the deletion of each of these genes has no relevant impact on P. aeruginosa pathogenicity in 
the G. mellonella model of infection (Fig. 3, Supplementary Fig. S4 and Table 3), clearly ruling out the 
corresponding proteins as potential targets for conventional antimicrobial drugs.
Notably, the G. mellonella infection model also revealed a different pathogenic behaviour of the lolA 
and lptH conditional mutants. Indeed, while LptH depletion almost completely abrogated P. aeruginosa 
infectivity in G. mellonella larvae, LolA depletion only resulted in a 25-fold increase in the LD90 (Fig. 3 
and Table 3). A similar trend was also observed in a mouse model of lung infection, although the high 
infecting doses required to establish the infection in this model likely mitigated the differences between 
the two conditional mutants, as well as between conditional mutants and the wild type strain (Fig. 4). 
Figure 4. Pathogenicity of lptH and lolA conditional mutants in a mouse lung infection model.  
(a) Mortality and (b) body weight curves for mice (n = 8) infected with 107 or 108 cells of PAO1, the 
lptH or the lolA conditional mutant, previously cultured in TSB supplemented with 0.5% arabinose. Data 
were pooled from two independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001. The asterisks in panel 
b refer to the differences between mice infected with 107 cells of the lptH and lolA conditional mutants.
www.nature.com/scientificreports/
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One could hypothesize that small amounts of arabinose possibly present in G. mellonella hemolymph or 
in the mouse lung could trigger sufficient lolA expression to promote growth of the arabinose-dependent 
conditional mutant. While to the best of our knowledge arabinose levels in G. mellonella larvae have not 
been investigated to date, arabinose concentration was found to be ≤ 0.02 mg/ml in mouse serum28 (cor-
responding to 0.002%), and should reasonably be even lower in the lung. This arabinose concentration is 
far below that required to induce growth of the lolA conditional mutant in vitro (Supplementary Fig. S6), 
indirectly ruling out that the observed pathogenicity in vivo may be due to arabinose-dependent resto-
ration of LolA expression. This is further corroborated by the different pathogenic behaviour in animal 
models observed for the lptH conditional mutant, which carries the same arabinose-dependent regula-
tory element and shows an in vitro response to increasing arabinose concentrations overall comparable 
to the lolA mutant (Supplementary Fig. S6).
Although the inability to obtain a lolA deletion mutant does not allow to definitely conclude that LolA, 
even at low intracellular levels, is not required for P. aeruginosa virulence, the residual pathogenicity of the 
lolA conditional mutant in animal models suggests that P. aeruginosa cells are viable and can grow in vivo 
with an impaired transport of lipoproteins to the outer membrane. By combining all the whole-genome 
transposon mutagenesis data available so far14,15,26,27,29, we found that only one of the 135 putative outer 
membrane lipoproteins of P. aeruginosa30 was predicted to be essential for in vitro growth in all exper-
imental conditions tested. This protein corresponds to the E. coli LolB homologue (PA4668), which 
is responsible for lipoprotein anchoring into the outer membrane31,32. However, the above-mentioned 
transposon mutagenesis studies also predicted lolA as an essential gene in P. aeruginosa14,15,26,27,29, in 
agreement with our in vitro results in laboratory media (Fig. 1 and Fig. S2), suggesting that the growth 
conditions tested in those studies could not be suitable to appreciate the residual growth and infectivity 
of LolA-depleted cells that we observed in vivo. Although further studies are clearly required to char-
acterize at the biochemical and ultrastructural level the outer membrane of LolA-depleted cells during 
in vivo growth, as well as to decipher the in vivo factor(s) associated with the restored growth of the lolA 
conditional mutant during infection, from a clinical point of view our findings argue against LolA as an 
ideal target for anti-P. aeruginosa drug development, since LolA inhibition could only partially affect P. 
aeruginosa growth and persistence during infections. Notably, while the essential role of E. coli LolA for 
in vitro growth is well known since many years33, and its mechanism of action has been investigated in 
great detail34, the infectivity of E. coli cells depleted of LolA has never been assessed in animal models. 
Thus, considering that our in vivo results provide evidence of partially-retained infectivity of P. aerug-
inosa cells impaired in lipoproteins transport, it would be interesting to verify the pathogenic role of 
LolA both in the model bacterium E. coli and in other Gram-negative bacteria in which lolA homologues 
have been predicted to be essential by in vitro large-scale mutagenesis studies (e.g., Vibrio, Haemophilus, 
Acinetobacter, Burkholderia, Helicobacter; http://www.essentialgene.org/).
In contrast, LptH depletion in P. aeruginosa resulted in growth inhibition and loss of cell viability in vitro 
(Fig. 1), as well as in almost complete abrogation of the ability to cause infection in different animal models 
(Table 3 and Fig. 4). Notably, an inhibitor of LPS transport in P. aeruginosa has already been reported35. 
This peptidomimetic blocks LPS translocation across the outer membrane by inhibiting the activity of the 
outer membrane protein LptD36, and was demonstrated to prevent P. aeruginosa lethality in a mouse sep-
ticemia model35. The in vitro and in vivo results obtained here with the lptH conditional mutant, together 
with the recently-disclosed three-dimensional structure of P. aeruginosa LptH18 and the above-mentioned 
pharmacological demonstration of LPS transport as a suitable drug target in P. aeruginosa35, provide strong 
support for further investigation of the druggability of the P. aeruginosa LptH protein.
More generally, our study highlights that experimental validation of putative essential genes, based on 
both in vitro and in vivo evidence, is important to confirm the results from high-throughput transposon 
mutagenesis, and crucial to propose novel potential molecular targets for antibacterial drug discovery 
programs.
Methods
Bacterial growth conditions. Bacterial strains used in this study are listed in Table 2. Unless oth-
erwise stated, growth assays were performed at 37 °C in microtiter plates in MH, LB (Acumedia) or M9 
minimal medium37 supplemented with 50 μ M FeCl3 and either 20 mM succinate or 20 mM glucose as 
the carbon source. When required, arabinose was added to growth media at the indicated concentra-
tion. Bacterial growth was assessed by measuring the OD600 of the bacterial cultures in a Victor plate 
reader (Wallac). When indicated, bacterial growth was also evaluated by determining the number of 
CFU/ml.
Construction of plasmids, deletion and conditional mutants. Plasmids and primers used 
in this study are listed in Supplementary Tables S1 and S2, respectively. In-frame deletion of each 
gene of interest was obtained using the sacB-based suicide vector pDM4 as previously described38. 
pDM4 derivatives were generated by cloning ca. 500-bp long DNA fragments corresponding to the 
upstream and downstream genomic regions of each gene of interest in the sequencing vector pBlue-
script II (Stratagene). After DNA sequencing check, the upstream and downstream fragments were 
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excised from pBluescript II and sub-cloned into pDM4. The restriction sites used for cloning are listed 
in Supplementary Table S2.
Conditional mutagenesis was performed using a recently-described strategy19. Briefly, a mini-CTX1 
derivative carrying the coding sequence of each gene of interest under the control of an arabinose-dependent 
regulatory element, which includes the araC gene, the PBAD promoter and a modified ribosome binding 
site to reduce the basal level of expression39, was inserted into a neutral site of the P. aeruginosa genome. 
Then, in-frame deletion of the endogenous genes was performed by using specific pDM4 derivatives 
under permissive conditions (i.e. growth in the presence of 0.5% arabinose). Mini-CTX1 derivatives 
were generated by replacing the tolB gene in mini-CTX1-araCPBADtolB19 with the coding sequence of 
each gene of interest. Gene deletion and insertion events were verified by PCR and DNA sequencing.
Detergent sensitivity assay. Sensitivity to the lytic effect of SDS was assessed as previously 
described19, by determining the turbidity (OD600) of bacterial cell suspensions in saline after 5-min incu-
bation at room temperature in the presence of increasing SDS concentrations (0–5%).
G. mellonella infection assay. P. aeruginosa strains were grown in MH with 0.5% arabinose, and 
serial dilutions of bacterial cell suspensions in saline were injected into G. mellonella larvae as described20. 
Larvae were incubated at 30 °C for one week to monitor mortality. Each strain was tested in at least three 
independent experiments. The LD90 was determined using the GraphPad Prism software as previously 
described40. The number of viable cells in dead larvae was determined by plating serial dilutions of the 
larval hemolymph in saline on MH agar plates supplemented with 100 μ g/ml of ampicillin (to which 
P. aeruginosa is intrinsically insensitive19) and/or 0.5% arabinose.
Mouse lung infection model. C57Bl/6 mice (20–22 gr) were purchased from Charles River. Mice 
were housed in filtered cages under specific-pathogen conditions and permitted unlimited access to 
food and water. Prior to animal experiments, the parental strain P. aeruginosa PAO1 and the lptH and 
lolA conditional mutants were grown for 3 h to reach exponential phase in TSB with 0.5% arabinose. 
Next, bacterial cells were pelleted by centrifugation (2,700 × g for 15 min), washed twice with sterile 
PBS and the OD of the bacterial suspension was adjusted by spectrophotometry at 600 nm. Mice were 
anesthetized and the trachea directly visualized by a ventral midline incision, exposed and intubated 
with a sterile, flexible 22-g cannula attached to a 1 ml syringe according to established procedures21. A 
50 μ l inoculum of 107 or 108 CFU of PAO1, lptH or lolA were implanted via the cannula into the lung, 
with both lobes inoculated. After infection, mortality and body weight were monitored over one week. 
The animals were handled in compliance with European Communities Council Directive 86/609 for the 
care of laboratory animals and ethical guidelines for research in animals. All procedures were approved 
by the Institutional Animal Care and Use Committee (IACUC) of the San Raffaele Scientific Institute 
(Milan, Italy) and adhered strictly to the Italian Ministry of Health guidelines for the use and care of 
experimental animals.
Bioinformatics predictions. Protein subcellular localization, presence of signal peptide for protein 
export and of transmembrane helices (TMHs) were predicted with the PSORTb Subcellular Localization 
Prediction Tool (www.psort.org/psortb/), the SignalP 4.1 Server (http://www.cbs.dtu.dk/services/
SignalP/) and the TMHMM Server 2.0 (http://www.cbs.dtu.dk/services/TMHMM/), respectively.
Statistical analysis. Two-way ANOVA with Bonferroni’s multiple comparison test was used to com-
pare change in body weight. Survival curves for the mouse infection assay were analyzed using the 
log-rank Mantel–Cox test. Statistical analysis was performed with the software GraphPad.
References
1. Pendleton, J. N., Gorman, S. P. & Gilmore, B. F. Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti Infect. Ther. 11, 
297–308 (2013).
2. Gaspar, M. C., Couet, W., Olivier, J. C., Pais, A. A. & Sousa, J. J. Pseudomonas aeruginosa infection in cystic fibrosis lung disease 
and new perspectives of treatment: a review. Eur. J. Clin. Microbiol. Infect. Dis. 32, 1231–1252 (2013).
3. Driscoll, J. A., Brody, S. L. & Kollef, M. H. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. 
Drugs 67, 351–368 (2007).
4. Breidenstein, E. B., de la Fuente-Núñez, C. & Hancock, R. E. Pseudomonas aeruginosa: all roads lead to resistance. Trends 
Microbiol. 19, 419–426 (2011).
5. Poole, K. Pseudomonas aeruginosa: resistance to the max. Front. Microbiol. 2, 65 (2011).
6. Livermore, D. M. The need for new antibiotics. Clin. Microbiol. Infect. 4, 1–9 (2004).
7. Page, M. G. & Heim, J. Prospects for the next anti-Pseudomonas drug. Curr. Opin. Pharmacol. 9, 558–565 (2009).
8. Walsh, C. T. & Wencewicz, T. A. Prospects for new antibiotics: a molecule-centered perspective. J. Antibiot (Tokyo) 67, 7–22 
(2014).
9. Lewenza, S., Gardy, J. L., Brinkman, F. S. & Hancock, R. E. Genome-wide identification of Pseudomonas aeruginosa exported 
proteins using a consensus computational strategy combined with a laboratory-based PhoA fusion screen. Genome Res. 15, 
321–329 (2005).
10. Silhavy, T. J., Kahne. D. & Walker, S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2, a000414 (2010).
11. Korotkov, K. V., Sandkvist, M. & Hol, W. G. The type II secretion system: biogenesis, molecular architecture and mechanism. 
Nat. Rev. Microbiol. 10, 336–51 (2012).
www.nature.com/scientificreports/
1 0Scientific RepoRts | 5:17593 | DOI: 10.1038/srep17593
12. Dé, E. et al. Membrane proteomes of Pseudomonas aeruginosa and Acinetobacter baumannii. Pathol. Biol (Paris) 59, e136–139 
(2011).
13. Imperi, F. et al. Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic 
pathogen. Proteomics 9, 1901–1915 (2009).
14. Jacobs, M. A. et al. Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 100, 
14339–14344 (2003).
15. Liberati, N. T. et al. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. 
Proc. Natl. Acad. Sci. USA 103, 2833–2838 (2006).
16. Bos, M. P., Robert, V. & Tommassen, J. Biogenesis of the gram-negative bacterial outer membrane. Annu. Rev. Microbiol. 61, 
191–214 (2007).
17. Sperandeo, P., Dehò, G. & Polissi, A. The lipopolysaccharide transport system of Gram-negative bacteria. Biochim. Biophys. Acta. 
1791, 594–602 (2009).
18. Bollati, M. et al. Crystal structure of LptH, the periplasmic component of the lipopolysaccharide transport machinery from 
Pseudomonas aeruginosa. FEBS J. 282, 1980–1997 (2015).
19. Lo Sciuto, A., Fernández-Piñar, R., Bertuccini, L., Iosi, F., Superti, F. & Imperi, F. The periplasmic protein TolB as a potential 
drug target in Pseudomonas aeruginosa. PLoS One 9, e103784 (2014).
20. Jander, G., Rahme, L. G. & Ausubel, F. M. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice 
and insects. J. Bacteriol. 182, 3843–3845 (2000).
21. Lorè, N. I. et al. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts. PLoS 
One 7, e35648 (2012).
22. Freire-Moran, L. et al. Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is 
now. Drug Resist. Updat. 14, 118–124 (2011).
23. Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455–459 (2015).
24. Deng, J., Su, S., Lin, X., Hassett, D. J. & Lu, L. J. A statistical framework for improving genomic annotations of prokaryotic 
essential genes. PLoS One 8, e58178 (2013).
25. Poole, K. Efflux-mediated multiresistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10, 12–26 (2004).
26. Turner, K. H., Wessel, A. K., Palmer, G. C., Murray, J. L & Whiteley, M. Essential genome of Pseudomonas aeruginosa in cystic 
fibrosis sputum. Proc. Natl. Acad. Sci. USA 112, 4110–4115 (2015).
27. Lee, S. A. et al. General and condition-specific essential functions of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 112, 
5189–5194 (2015).
28. Loessner, H. et al. Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as 
inducer of bacterial gene expression in vivo. Cell. Microbiol. 9, 1529–1537 (2007).
29. Skurnik, D. et al. A comprehensive analysis of in vitro and in vivo genetic fitness of Pseudomonas aeruginosa using high-
throughput sequencing of transposon libraries. PLoS Pathog. 9, e1003582 (2013).
30. Remans, K., Vercammen, K., Bodilis, J. & Cornelis, P. Genome-wide analysis and literature-based survey of lipoproteins in 
Pseudomonas aeruginosa. Microbiology 156, 2597–2607 (2010).
31. Tsukahara, J., Mukaiyama, K., Okuda, S., Narita, S. & Tokuda, H. Dissection of LolB function–lipoprotein binding, membrane 
targeting and incorporation of lipoproteins into lipid bilayers. FEBS J. 276, 4496–4504 (2009).
32. Hoang, H. H. et al. Outer membrane targeting of Pseudomonas aeruginosa proteins shows variable dependence on the components 
of Bam and Lol machineries. MBio 2, e00246–11 (2011).
33. Tajima, T., Yokota, N., Matsuyama, S. & Tokuda, H. Genetic analyses of the in vivo function of LolA, a periplasmic chaperone 
involved in the outer membrane localization of Escherichia coli lipoproteins. FEBS Lett. 439, 51–54 (1998).
34. Okuda, S. & Tokuda, H. Model of mouth-to-mouth transfer of bacterial lipoproteins through inner membrane LolC, periplasmic 
LolA, and outer membrane LolB. Proc. Natl. Acad. Sci. USA 106, 5877–5882 (2009).
35. Srinivas, N. et al. Peptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosa. Science. 327, 
1010–1013 (2010).
36. Werneburg, M. et al. Inhibition of lipopolysaccharide transport to the outer membrane in Pseudomonas aeruginosa by 
peptidomimetic antibiotics. Chembiochem. 13, 1767–1775 (2012).
37. Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, 1989).
38. Milton, D. L., O’Toole, R., Horstedt, P. & Wolf-Watz, H. Flagellin A is essential for the virulence of Vibrio anguillarum. J. 
Bacteriol. 178, 1310–1319 (1996).
39. Mdluli, K. E. et al. Molecular validation of LpxC as an antibacterial drug target in Pseudomonas aeruginosa. Antimicrob. Agents 
Chemother 50, 2178–2184 (2006).
40. Antunes, L. C., Imperi, F., Carattoli, A. & Visca, P. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. 
PLoS One 6, e22674 (2011).
41. Liss, L. New M13 host: DH5 F′ competent cells. Focus 9, 13 (1987).
42. Simon, R., Priefer, U. & Pühler, A. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis 
in Gram negative bacteria. Bio/Technology 1, 784–790 (1983).
Acknowledgements
We are grateful to Arianna Fasoli and Shirley Genah for the valuable experimental contribution during 
the preparation of their bachelor or master degree theses. Regina Fernández-Piñar was supported by 
a postdoctoral fellowship from the Fundación Alfonso Martín Escudero (Spain). Research in the F.I. 
laboratory is supported by the Pasteur Institute-Cenci Bolognetti Foundation and the Italian Cystic 
Fibrosis Research Foundation (grant FFC#10/2013).
Author Contributions
R.F., A.L., A.R., S.R and F.I. performed the experiments; R.F., A.B. and F.I. planned the experiments; F.I. 
conceived the study and wrote the manuscript. All authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:17593 | DOI: 10.1038/srep17593
How to cite this article: Fernández-Piñar, R. et al.  In vitro and  in vivo screening for novel essential 
cell-envelope proteins in  Pseudomonas aeruginosa . Sci. Rep. 5, 17593; doi: 10.1038/srep17593 (2015).
This work is licensed under a Creative Commons Attribution 4.0 International License. The 
images or other third party material in this article are included in the article’s Creative Com-
mons license, unless indicated otherwise in the credit line; if the material is not included under the 
Creative Commons license, users will need to obtain permission from the license holder to reproduce 
the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
